Estela Rodriguez: Timely Diagnosis and Biomarker Testing key in ROS1+ Lung Cancer
Estela Rodriguez/LinkedIn

Estela Rodriguez: Timely Diagnosis and Biomarker Testing key in ROS1+ Lung Cancer

Estela Rodriguez, Associate Director of Community Outreach-Thoracic Oncology at Sylvester Comprehensive Cancer Center shared a post on X:

“Recorded a virtual tumor board today on ROS1+ lung cancer, highlighting the importance of timely diagnosis, comprehensive biomarker testing, and the evolving treatment landscape.

Raising awareness is key to ensuring patients receive the right therapy at the right time.”

Estela Rodriguez: Timely Diagnosis and Biomarker Testing key in ROS1+ Lung Cancer

Other artciles featuring Estela Rodriguez on OncoDaily.